RPAM
CLVS

Rhenman & Partners Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History

Rhenman & Partners Asset Management’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
2015
Q4 		$2.56M Buy
2015
Q3 		$3.95M Sell
2015
Q2 		$5.34M Buy
2015
Q1 		$4.01M Sell
2014
Q4 		$4.78M Buy
2014
Q3 		$2.59M Sell
2014
Q2 		$3.73M Buy